JSPRW Jasper Therapeutics, Inc. - Warrant
$0,01
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 14, 2026
Rango 52S
$0–$0
34% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
—
ROE
-548.2%
Margen de Beneficio Neto
—
JSPRW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.01
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-3.95
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-548.2%
Deuda/Capital
—
Rango 52S
$0 – $0
JSPRW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-3.95
2021-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
ROA
-131.1%
—
ROE
-548.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Current Ratio (Ratio corriente)
2.6
—
Quick Ratio (Ratio Rápido)
2.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | $42M | $34M | · | · | · | · | |
| R&D Expense | $63M | $56M | $52M | $35M | $25M | $16M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $11M | $5M | |
| Operating Expenses | $84M | $76M | $69M | $51M | $37M | $21M | |
| Operating Income | $-84M | $-76M | $-69M | $-51M | $-37M | $-21M | |
| Interest Income | $2M | $5M | $5M | $701.0K | · | · | |
| Other Non-op | $-2M | $-88.0K | $-246.0K | $586.0K | $-80.0K | · | |
| Pretax Income | · | · | · | · | · | $-6M | |
| Income Tax | · | $2.0K | $2.0K | · | · | · | |
| Net Income | $-76M | $-71M | $-64M | $-38M | $-31M | $-32M | |
| EPS (Basic) | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | · | |
| EPS (Diluted) | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | · | |
| Shares (Basic) | 19,168,110 | 14,584,870 | 10,439,034 | 3,648,140 | 11,393,753 | · | |
| Shares (Diluted) | 19,168,110 | 14,584,870 | 10,439,034 | 3,648,140 | 11,393,753 | · | |
| EBITDA | $-84M | $-76M | $-68M | $-51M | $-37M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $72M | $87M | $38M | $85M | $20M | |
| Prepaid Expense | $6M | $4M | $2M | $3M | $3M | $247.0K | |
| Other Current Assets | $664.0K | $646.0K | $295.0K | $118.0K | $219.0K | · | |
| Current Assets | $35M | $76M | $89M | $42M | $88M | $21M | |
| PP&E (Net) | $102.0K | $2M | $3M | $4M | $4M | $693.0K | |
| PP&E (Gross) | $5M | $6M | $5M | $5M | $4M | $693.0K | |
| Accum. Depreciation | $5M | $4M | $2M | $1M | $377.0K | · | |
| Other Non-current Assets | $113.0K | $820.0K | $1M | $759.0K | $645.0K | $298.0K | |
| Total Assets | $36M | $80M | $95M | $48M | $94M | $23M | |
| Accounts Payable | $6M | $4M | $4M | $2M | $4M | $1M | |
| Accrued Liabilities | · | · | · | · | · | $925.0K | |
| Current Liabilities | $13M | $15M | $12M | $7M | $8M | $4M | |
| Capital Leases | · | $724.0K | $2M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $643.0K | $853.0K | |
| Total Liabilities | $32M | $18M | $16M | $12M | $24M | $15M | |
| Common Stock | $3.0K | $2.0K | $1.0K | · | $4.0K | $1.0K | |
| Paid-in Capital | $321M | $303M | $248M | $141M | $137M | $2M | |
| Retained Earnings | $-317M | $-241M | $-170M | $-105M | $-67M | $-37M | |
| Stockholders' Equity | $4M | $62M | $78M | $36M | $70M | $-35M | |
| Liabilities + Equity | $36M | $80M | $95M | $48M | $94M | $23M | |
| Shares Outstanding | 27,996,819 | 15,022,122 | 11,163,896 | 3,804,427 | 37,855,114 | 2,770,702 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $975.0K | $377.0K | · | |
| Stock-based Comp | $7M | $7M | $5M | $4M | $1M | $1M | |
| Other Non-cash | · | · | $6M | · | · | · | |
| Operating Cash Flow | $-77M | $-63M | $-52M | $-46M | $-34M | $-18M | |
| Investing Cash Flow | $5.0K | $-532.0K | $-267.0K | $-576.0K | $-2M | · | |
| Stock Issued | $6M | · | $101M | $28.0K | · | · | |
| Net Stock Activity | $6M | $47M | · | $28.0K | · | · | |
| Financing Cash Flow | $34M | $48M | $101M | $55.0K | $101M | $11M | |
| Net Change in Cash | · | · | · | · | · | $-442.6K |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 27992.3% | · | 46041.2% | · | |
| Net Margin | · | · | 26205.3% | · | 38296.2% | · | |
| EBITDA Margin | · | · | 27541.9% | · | 46041.2% | · | |
| ROA | -131.1% | -81.5% | -90.0% | -53.1% | -52.4% | · | |
| ROE | -548.2% | -98.1% | -74.7% | -90.2% | -41.4% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 5.0 | 7.2 | 5.9 | 11.0 | · | |
| Quick Ratio | 2.2 | 4.7 | 7.0 | 5.4 | 10.6 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | · | -0.0 | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-119.0K | $-119.0K | $-246.0K | $-115.0K | $-80.0K | $-111.0K | |
| Net Income TTM | $-76M | $-71M | $-64M | $-38M | $-31M | $-32M |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $4M | $7M | $9M | $16M | · | $13M | $9M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $5M | $11M | $14M | $21M | $16M | $20M | $14M | $11M | $10M | $14M | $15M | $13M | $10M | $9M | $9M | $8M | |
| SG&A Expense | $4M | $4M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $9M | $16M | $19M | $27M | $22M | $25M | $20M | $16M | $15M | $18M | $19M | $18M | $14M | $14M | $13M | $12M | |
| Operating Income | $-9M | $-16M | $-19M | $-27M | $-22M | $-25M | $-20M | $-16M | $-15M | $-18M | $-19M | $-18M | $-14M | $-14M | $-13M | $-12M | |
| Interest Income | $82.0K | $338.0K | $342.0K | $437.0K | $624.0K | $938.0K | $1M | $1M | $1M | $1M | $1M | $1M | · | $348.0K | $259.0K | · | |
| Other Non-op | $2M | $-29.0K | $-2M | $-84.0K | $-63.0K | $26.0K | $-32.0K | $-40.0K | $-42.0K | $-2M | $51.0K | $2M | $-313.0K | · | · | · | |
| Net Income | $-3M | $-9M | $-19M | $-27M | $-21M | $-24M | $-19M | $-15M | $-14M | $-17M | $-18M | $-16M | $-14M | $-13M | $-12M | $-10M | |
| EPS (Basic) | $-0.10 | $0.33 | $-1.13 | $-1.74 | $-1.41 | $-1.65 | $-1.24 | $-0.97 | $-1.03 | $-1.49 | $-1.60 | $-1.47 | $-1.62 | $-9.66 | $-0.32 | $-0.29 | |
| EPS (Diluted) | $-0.10 | $0.33 | $-1.13 | $-1.74 | $-1.41 | $-1.65 | $-1.24 | $-0.97 | $-1.03 | $-1.49 | $-1.60 | $-1.47 | $-1.62 | $-9.66 | $-0.32 | $-0.29 | |
| Shares (Basic) | 28,696,937 | -27,823,758 | 16,635,784 | 15,333,962 | 15,022,122 | -28,736,913 | 15,000,516 | 14,986,367 | 13,334,900 | -20,241,906 | 10,971,945 | 10,921,239 | 8,787,756 | -105,625,015 | 36,565,650 | 36,397,822 | |
| Shares (Diluted) | 28,696,937 | -27,823,758 | 16,635,784 | 15,333,962 | 15,022,122 | -28,736,913 | 15,000,516 | 14,986,367 | 13,334,900 | -20,241,906 | 10,971,945 | 10,921,239 | 8,787,756 | -105,625,015 | 36,565,650 | 36,397,822 | |
| EBITDA | $-9M | · | $-19M | $-27M | $-22M | · | $-20M | $-16M | $-15M | · | $-19M | $-18M | $-14M | · | $-13M | $-12M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $29M | $51M | $40M | $49M | $72M | $93M | $107M | $118M | $87M | $104M | $116M | $129M | $38M | $51M | $61M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $3M | $3M | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $2M | $1M | $3M | $3M | $3M | $1M | $2M | |
| Other Current Assets | $255.0K | $664.0K | $863.0K | $867.0K | $854.0K | $646.0K | $625.0K | $475.0K | $440.0K | $295.0K | · | $653.0K | $721.0K | $118.0K | $430.0K | $27.0K | |
| Current Assets | $12M | $35M | $55M | $43M | $53M | $76M | $95M | $109M | $120M | $89M | $105M | $119M | $133M | $42M | $52M | $63M | |
| PP&E (Net) | $60.0K | $102.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | |
| PP&E (Gross) | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $811.0K | |
| Other Non-current Assets | $43.0K | $113.0K | $150.0K | $192.0K | $532.0K | $820.0K | $1M | $1M | $1M | $1M | $411.0K | $445.0K | $725.0K | $759.0K | $543.0K | $577.0K | |
| Total Assets | $12M | $36M | $57M | $46M | $58M | $80M | $99M | $114M | $126M | $95M | $110M | $124M | $139M | $48M | $59M | $70M | |
| Accounts Payable | $3M | $6M | $9M | $8M | $3M | $4M | $3M | $3M | $2M | $4M | $3M | $2M | $4M | $2M | $3M | $3M | |
| Current Liabilities | $8M | $13M | $21M | $20M | $12M | $15M | $12M | $10M | $9M | $12M | $12M | $9M | $8M | $7M | $7M | $7M | |
| Capital Leases | · | · | · | $201.0K | $755.0K | $724.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| Other Non-current Liabilities | · | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $707.0K | $749.0K | |
| Total Liabilities | $10M | $32M | $46M | $23M | $15M | $18M | $16M | $14M | $13M | $16M | $16M | $14M | $14M | $12M | $12M | $12M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $11.0K | $11.0K | $11.0K | · | $4.0K | $4.0K | |
| Paid-in Capital | $322M | $321M | $319M | $312M | $304M | $303M | $300M | $298M | $297M | $248M | $247M | $246M | $245M | $141M | $139M | $139M | |
| Retained Earnings | $-321M | $-317M | $-308M | $-289M | $-262M | $-241M | $-217M | $-198M | $-183M | $-170M | $-153M | $-135M | $-119M | $-105M | $-92M | $-80M | |
| Stockholders' Equity | $1M | $4M | $12M | $24M | $42M | $62M | $84M | $100M | $113M | $78M | $94M | $110M | $125M | $36M | $48M | $59M | |
| Liabilities + Equity | $12M | $36M | $57M | $46M | $58M | $80M | $99M | $114M | $126M | $95M | $110M | $124M | $139M | $48M | $59M | $70M | |
| Shares Outstanding | 28,079,552 | 27,996,819 | 27,984,039 | 16,219,243 | 15,022,122 | 15,022,122 | 15,001,353 | 15,105,300 | 15,085,553 | 11,163,896 | 110,850,413 | 110,800,413 | 109,428,211 | 3,804,427 | 37,984,368 | 37,981,317 |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21.0K | $290.0K | $229.0K | $258.0K | $279.0K | $285.0K | $500.0K | $300.0K | $288.0K | $234.0K | $300.0K | $300.0K | $274.0K | $273.0K | $300.0K | $218.0K | |
| Stock-based Comp | $764.0K | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $644.0K | $1M | |
| Operating Cash Flow | $-7M | $-22M | $-17M | $-15M | $-23M | $-21M | $-14M | $-12M | $-16M | $-16M | $-12M | $-13M | $-10M | $-13M | $-10M | $-9M | |
| Investing Cash Flow | · | $0 | $0 | $1.0K | $4.0K | $-76.0K | $-274.0K | $-157.0K | $-25.0K | $-230.0K | $0 | $-11.0K | $-26.0K | $-82.0K | $-222.0K | $-243.0K | |
| Stock Issued | · | $0 | $514.0K | · | · | · | $0 | $0 | $47M | $0 | $0 | $0 | $101M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $47M | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | $-340.0K | $28M | · | · | $345.0K | $9.0K | $181.0K | $47M | $-271.0K | $36.0K | $-305.0K | $102M | $28.0K | $1.0K | $13.0K |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -37964.7% | 16355.0% | 19924.3% | · | -4741.8% | -13441.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -34400.0% | 14752.3% | 20371.4% | · | -4426.5% | -11689.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -37376.5% | 16355.0% | 19924.3% | · | -4741.8% | -13441.6% | |
| ROA | -9.5% | · | -23.9% | -33.3% | -23.1% | · | -17.8% | -12.2% | -10.4% | · | -20.7% | -16.5% | -13.0% | · | -14.3% | -12.2% | |
| ROE | -22.2% | · | -39.3% | -43.2% | -27.3% | · | -21.0% | -13.9% | -11.5% | · | -24.8% | -19.0% | -14.8% | · | -18.8% | -32.6% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | · | 2.6 | 2.1 | 4.3 | · | 7.6 | 10.8 | 13.5 | · | 8.8 | 13.2 | 16.8 | · | 7.1 | 9.6 | |
| Quick Ratio | 0.9 | · | 2.4 | 1.9 | 4.0 | · | 7.4 | 10.6 | 13.3 | · | 9.0 | 13.3 | 16.4 | · | 6.9 | 9.2 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | -0.0 | -0.0 | · | 0.0 | 0.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-119.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | $-173.0K | $-138.0K | · | $-77.0K | $-82.0K | |
| Net Income TTM | $-49M | · | $-85M | $-81M | $-68M | · | $-64M | $-62M | $-62M | · | $-60M | $-53M | $-39M | · | $-28M | $-24M | |
| Market Cap | $572.8K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | -4.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -14754.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | — | — | 27992.3% | — | 46041.2% |
| Beneficio neto | $-76M | $-71M | $-64M | $-38M | $-31M |
| EPS Diluido | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.6 | 5.0 | 7.2 | 5.9 | 11.0 |
| Ratio Rápido | 2.2 | 4.7 | 7.0 | 5.4 | 10.6 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 7 declarantes · $187K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 0 (-2 vs trimestre anterior) | 1 (-3 vs trimestre anterior) | 1 (0 vs trimestre anterior) | 1 (+1 vs trimestre anterior) | -28K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $150 485 | 357 447 | 80,44% | Acciones |
| TORONTO DOMINION BANK | $30 446 | 2 174 682 | 16,28% | Acciones |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $3 375 | 250 000 | 1,80% | Acciones |
| Walleye Capital LLC | $2 700 | 200 000 | 1,44% | Acciones |
| JPMORGAN CHASE & CO | $40 | 2 941 | 0,02% | Acciones |
| WOLVERINE ASSET MANAGEMENT LLC | $22 | 1 639 | 0,01% | Acciones |
| IFP Advisors, Inc | $1 | 50 | 0,00% | Acciones |
Informantes de la empresa 9 insiders · 2 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| VENKATARAMAN BALAJI | Chief Executive Officer | 3 de enero de 2020 J | — | 0 | 0 | $0 |
| Kenneth F Clifford | Chief Financial Officer | 3 de enero de 2020 J | — | 0 | 0 | $0 |
| Judith Anne Shizuru | Consejero | 31 de julio de 2026 A | — | 0 | 0 | $0 |
| Svetlana Lucas | Consejero | 31 de julio de 2026 A | — | 0 | 0 | $0 |
| Patrick J Crutcher | Consejero | 31 de julio de 2026 A | — | 0 | 0 | $0 |
| Kurt Von Emster | Consejero | 31 de julio de 2026 A | — | 0 | 0 | $0 |
| Thomas G Wiggans | Consejero | 31 de julio de 2026 A | — | 0 | 0 | $0 |
| Howard I Hoffen | Consejero | 3 de enero de 2020 J | — | 0 | 0 | $0 |
| Amplitude Healthcare Holdings LLC | Propietario del 10% | 3 de enero de 2020 J | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto